Vivodyne
Vivodyne

Vivodyne

DR31Ahrefs DR: 31/100. Below median. Measured by Ahrefs. Median 44.Agent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Speed59Site Speed: 59/100. Below median. Measured by Google PageSpeed. Median 62.

Vivodyne is developing advanced AI models for drug discovery and development.

2021Active41New York, United States

About

Vivodyne revolutionizes therapeutics development by providing preclinical human data before clinical trials. Their platform utilizes ultra-realistic, lab-grown human organ tissue models and predictive AI to accelerate the discovery and optimization of new therapies. They partner with biopharma companies to advance new targets and bring better therapeutics to patients.

Key facts

At-a-glance profile data

Website
vivodyne.com
Headquarters
New York, United States
Founded
2021
Employees
41
Total funding
$40M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Vivodyne
DateRoundAmountLead investors
31 May 2025Seed$40M-

Tech stack

Detected on vivodyne.com and in its job posts, last scanned 4 Sept 2026. Run your own scan

Frontend
Bootstrap, React, Tailwind CSS, TypeScript
Backend
Python, FastAPI
Database
PostgreSQL
Auth
Auth0
CMS / Builders
Webflow
CDN
Cloudflare
Hosting
AWS
Email provider
Google Workspace
Hiring platform
Greenhouse
Add first review

Frequently asked

How much funding has Vivodyne raised?

Vivodyne has raised a total of $40M in funding. The most recent round on record is Seed.

How many employees does Vivodyne have?

Vivodyne has approximately 41 people on record.